Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 390 followers
Latest posts
Last updated about 2 hours ago
Why human expertise still matters in AI-driven med comms
about 2 hours ago
RTI Health Solutions experts explain how AI can help medical communications without...
Novo gets Chamber of Commerce backing in bid to bring IRA challenge to Supreme Court
about 2 hours ago
On Wednesday, the U.S. Chamber of Commerce filed an amicus brief calling...
HER2+ Metastatic Gastroesophageal Adenocarcinoma: Why First-Line Innovation Can’t Wait
about 3 hours ago
Outcomes for HER2+ metastatic gastroesophageal adenocarcinoma remain poor, underscoring the need for...
Hims & Hers uses another Super Bowl ad to tackle healthcare affordability
about 3 hours ago
The minute-long ad, which debuted online Thursday ahead of its broadcast premiere...
Takeda, still in a Vyvanse slog, lifts guidance as it looks to new wave of growth
about 4 hours ago
The gap between Vyvanse generic sales declines and growth from new products...
ARS Pharma TV ad for epinephrine nasal spray Neffy needled by FDA in untitled letter
about 5 hours ago
A few months after sending an untitled letter to ARS Pharmaceuticals, taking...
Sanofi’s vaccine ambitions unfazed by ‘politics or sentiment in the now,’ CEO Hudson says
about 5 hours ago
Amid mounting concerns about the state of vaccine policy in the United...
As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study
about 6 hours ago
Roche is looking to a busy 2026 after 10 new molecules entered...
Bayer broadcasts patient stories with Tony Romo calling plays in Nubeqa drive
about 6 hours ago
Bayer has unveiled the next play in its Nubeqa marketing strategy, tapping...
'Relax your tight end': Novartis Super Bowl ad drafts NFL stars for cheeky prostate cancer testing push
about 8 hours ago
A year after debuting its first Super Bowl ad, Novartis is returning...
Tenpoint scores FDA nod for vision-correction eye drop Yuvezzi, plans Q2 launch with $235M in tow
about 9 hours ago
Combining two eye drops that have been on the market for at...
AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
about 9 hours ago
AstraZeneca has outlined plans to invest $15 billion in China through 2030...